Q1 2024 Definitive Healthcare Corp Earnings Call Transcript
Key Points
- Definitive Healthcare Corp (DH) met its revenue guidance for Q1 2024, achieving $63.5 million, a 7% year-over-year growth.
- Adjusted EBITDA was strong at $20.0 million, reflecting a 32% margin and demonstrating significant margin expansion.
- The company delivered record unlevered free cash flow of over $28 million during the quarter.
- Customer renewal rates improved, indicating increased customer satisfaction and retention.
- Operational efficiencies were enhanced following a restructuring, which is expected to position DH for long-term profitable growth.
- DH underperformed its new logo and upsell expectations due to macroeconomic headwinds and disruptions from restructuring.
- Sales cycles remained elongated as buyers continued to scrutinize spending in a cost-conscious environment.
- The restructuring led to significant disruption in sales efforts during the first two months of the year.
- Total customer count decreased from Q1 2023, indicating a drop in smaller customer segments.
- Guidance for future revenue and adjusted EBITDA was adjusted downwards due to a slower-than-expected start to the year.
Welcome to Definitive Healthcare's Q1 2024 earnings call. Our host for today's call is Jason Krantz. (Operator Instructions)
I would now like to turn the call over to your host, Mr. Krantz, you may begin.
Good afternoon and thank you for joining us today to review Definitive Healthcare's financial results. Joining me on the call today are Jason Krantz, our Founder, Executive Chairman and Interim CEO; and Rick Booth, our CFO.
During this call, we will make forward-looking statements, including, but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our health care commercial intelligence solutions, our competitive position, customer behaviors and use of our solutions, our financial guidance, our planned investments, generating value for our customers and shareholders, and the anticipated impacts of global macroeconomic conditions on our business results and clients and on the health care
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
